|
|
|
|
|
by DiscourseFan
917 days ago
|
|
Well, not really, what (mass) mRNA trials have shown is that they don't deliver long term immunity, and each time you give someone an mRNA booster the immune reaction gets more severe, until the point at which it might give them serious long term side effects or even, in severe cases, kill them. It doesn't actually make sense in most cases to use mRNA over traditional vaccines--but they have been producing fascinating non-prophylactic immunotherapy treatments with mRNA, where triggering a severe, and specific, immune response would lead to positive results (like with specifically targeted cancer treatments). |
|
Melanoma in particular heads to the brain often and is difficult to treat. 10-15 years ago, it was a death sentence. Today, 60-70% of qualified patients will survive 5 years or more thanks to immunotherapy. A chunk of the 30-40% are folks who have difficulty tolerating the therapy, have poor response, or other complications. In my wife’s case, complications from brain surgery delayed treatment and the combo of mets and immunotherapy response created a bad situation.
Today, about 50% of melanoma tumors have a BRAF mutation, and a medication that can delay growth and buy patients time to get better in order to get treatment. In my wife’s case, that wasn’t an option.
COVID demonstrated that these vaccines bend the death curve, reduce severity and offer positive immune response. If that were available early this year, the chances are my wife would be alive, finishing her second course of immunotherapy.